Med. Pro Praxi 2007; 6: 259-261

Dysmotilita horní části zažívacího traktu u diabetu

MUDr. Vladimír Kojecký Ph.D
Interní klinika, Krajská nemocnice T. Bati a.s., Zlín

Diabetes mellitus ovlivňuje činnost řady orgánů. Zažívací trakt není výjimkou. Spektrum poruch je pestré. Výrazné patologie zjišťované při instrumentálních vyšetřeních jsou často asymptomatické. Za nejvýznamnější je považována gastroparéza a dysmotilita tenkého střeva. Léčba zahrnuje normalizaci glykémie, úpravu dietního režimu, prokinetika, antidiaroika. V posledních letech jsou zkoušena analoga některých gastrointestinálních hormonů.

Keywords: diabetes mellitus, gastroparéza, diabetický průjem, hyperglykémie, autonomní neuropatie

Published: September 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kojecký V. Dysmotilita horní části zažívacího traktu u diabetu. Med. praxi. 2007;4(6):259-261.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bertin E, Schneider N, Abdelli N et al. Gastric emptying is accelerated in obese type 2 diabetic patients without autonomic neuropathy. Diabetes Metab 2001; 3: 357-364.
    2. Camilleri M, Malagelada JR. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984; 6: 420-427. Go to original source... Go to PubMed...
    3. de Boer SY, Masclee AM, Jebbink MC et al. Effect of acute hyperglycaemia on gall bladder contraction induced by cholecystokinin in humans. Gut 1993; 8: 1128-1132. Go to original source... Go to PubMed...
    4. El-Salhy M. Neuroendocrine peptides of the gastrointestinal tract of an animal model of human type 2 diabetes mellitus. Acta Diabetol 1998; 4: 194-198. Go to original source... Go to PubMed...
    5. Feldman M, Schiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Arch Int Med 1983; 98: 378-384. Go to original source... Go to PubMed...
    6. Freeman R, Mivawaki E. The treatment of autonomic dysfunction. J Clin Neurophysiol 1993; 1: 61-82. Go to original source... Go to PubMed...
    7. Goyal KR, Hirano I. The enteric nervous system. N Engl J Med 1996; 17: 1106-1115. Go to original source... Go to PubMed...
    8. Haubrich WS, Schaffner F, Berk JE Bockus Gastroenterology, 5. edition, Philadelphia: Saunders 1995.
    9. Horowitz M, O´Donovan D, Jones KL et al. Gastric emptying in diabetes, clinical significance and treatment. Diabetic Medicine 2002; 3: 177-194. Go to original source... Go to PubMed...
    10. Horowitz M, Harding PE, Maddox AF et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1989; 3: 151-159. Go to original source... Go to PubMed...
    11. Jones KL, Horowitz M, Wishart J et al. Relationship between gastric emptying intragastric meal distribution and blood glucose concentrations in diabetes mellitus. J Nucl Med 1995; 12: 2220-2228.
    12. Keshavarzian A, Iber FL, Nasrallah S. Radionuclide esophageal emptying and manometric studies in diabetes mellitus. Am J Gastroenterol 1987; 7: 625-631. Go to original source... Go to PubMed...
    13. Kojecký V, Bernátek J, Bakala J, Weissová D. Vliv itopridu na rychlost a průběh evakuace žaludku diabetiků a jejich vztah ke kompenzaci diabetu. Čes a Slov Gastroenterol a Hepatol 2005, 59, 1, 17-20.
    14. Lacigová S, Rušavý Z, Mindlová J. Žaludeční vyprazdňování u diabetiků. Vnitř Lék 2000; 4: 213-217.
    15. Lluch I, Ascaso JF, Mora F et al. Gastroesophageal reflux in diabetes mellitus. Am J Gastroenterol 1999; 4: 919-924. Go to original source... Go to PubMed...
    16. Mariani G, Boni G, Barreca M et al. Radionuclide gastroesophageal motor studies. J Nucl Med 2004; 6: 1004-1028.
    17. Mittal RK, Bhalla V. Oesophageal motor functions and its disorders. Gut 2004; 10:, 1536-1542. Go to original source... Go to PubMed...
    18. Murray FE, Lombard MG, Ashe J et al. Esophageal function in diabates mellitus with special reference to acid studies and relationship to peripheral neuropathy. Am J Gastroenterol 1987; 9: 840-843.
    19. Rayner CK, Samsom M, Jones KL et al. Relationship of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001; 2: 371-381. Go to original source... Go to PubMed...
    20. Samsom M, Jebbink RJ, Akkermanns LM et al. Abnormalities in antroduodenal motility in type I diabetes. Diabetes Care 1996; 1: 21-27. Go to original source... Go to PubMed...
    21. Schvarcz E, Palmer M, Ingberg CM et al. Increased prevalence of upper gastrointestinal symptoms in long-term type 1 diabetes mellitus. Diabetic Medicine 1996; 5: 478-481. Go to original source...
    22. Smith DS, Ferris CD. Current concepts in diabetic gastroparesis. Drugs 2003; 13: 1339-1358. Go to original source... Go to PubMed...
    23. Stacher G. Diabetes mellitus and stomach. Diabetologia 2001; 9: 1080-1093. Go to original source... Go to PubMed...
    24. Stacher G, Lenglinger J, Bergmann H et al. Gastric emptying, a contributory factor in gastrooesophageal reflux activity? Gut 2000; 5: 661-666. Go to original source... Go to PubMed...
    25. Vinik AI, Maser RE, Mitchell BD et al. Diabetic autonomic neuropathy. Diabetes Care 2003; 5: 1553-1579. Go to original source... Go to PubMed...
    26. Talley NJ. Diabetic gastropathy and prokinetics. Am J Gastroenterol 2003; 2: 264-271. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.